Products/Services
Type
Country
Country
Status
Completed
Product/Service
Support to MoH and MHIF to implement newly adopted regulation on a selection of medicines into Additional Drug Package
Deliverables
- In line with the newly approved regulation, the Additional Drug Package has been revised, resulting in two lists: one featuring medicines recommended to remain in the ADP, and another detailing those suggested for removal from the ADP by end of December 2023;
Technical Areas
Health Financing
Pharma and Medical Products
Technical Contacts
moldoisaevas@who.int
Programme Implementation
100
GPW
GPW 13
GPW Output
1.3.3 Country and regional regulatory capacity strengthened, and supply of quality-assured and safe health products improved, including through prequalification services
GPW Outcome
1.3 Improved access to essential medicines, vaccines, diagnostics and devices for primary health care
Dates
to